Case series of nebulizing r‐tPA for COVID‐19 induced acute respiratory distress syndrome

Case series of nebulizing r‐tPA for COVID‐19 induced acute respiratory distress syndrome

Abstract Fibrin deposition in the alveolar spaces during pulmonary involvement of COVID‐19 impairs the O2/CO2 exchange and leads to respiratory symptoms. In this report, Recombinant Tissue Plasminogen Activator (r‐tPA) has been nebulized to 3 critically ill COVID‐19 patients in order to resolve the...

Full description

Bibliographic Details
Main Authors: Shahideh Amini, Zohre Labbani‐Motlagh, Rasoul Aliannejad, Seyed Mohammad Pourabbas, Mohammad Vasei
Format: Article
Language:English
Published: Wiley 2022-09-01
Series:Clinical Case Reports
Subjects:
ARDS
COVID‐19
fibrinolysis
recombinant tissue plasminogen activator
r‐tPA
Online Access:https://doi.org/10.1002/ccr3.6283

Internet

https://doi.org/10.1002/ccr3.6283

Similar Items